Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

TTIP documents released by the European Commission

 

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Regulatory cooperation under the proposed EU-US trade deal (TTIP) will strengthen corporate lobbyists’ hand

The ongoing EU-US trade negotiations, TTIP, seek to bring rules on both sides of the Atlantic together by means of so-called regulatory cooperation. Our new report with LobbyControl "Dangerous Regulatory Duet" finds that regulatory cooperation procedures have already been used to delay, water down and prevent legislation in the public interest.

Watch how corporations are using TTIP to promote their climate-trashing agenda.

Proposed special rights for corporations in EU trade deals such as CETA and TTIP threaten to prevent the necessary energy transition to tackle climate change. Polluting corporations are already using the dangerous investor privileges in trade and investment deals to challenge progressive energy policies.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

The voice of the Dutch Government has been loud and clear in Brussels on the issue of cisgenic plants. The Dutch have waged a sustained campaign to have new GM techniques – and in particular cisgenesis – excluded from EU GMO regulations. Several Dutch ministries, the Dutch Parliament, the Dutch Permanent Representation in Brussels, and Dutch MEPs have energetically pursued this goal.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate